Business NewsPR NewsWire • BrainStorm's NurOwn® for the Treatment of ALS Published in JAMA Neurology

BrainStorm's NurOwn® for the Treatment of ALS Published in JAMA Neurology

BrainStorm's NurOwn® for the Treatment of ALS Published in JAMA Neurology

HACKENSACK, N.J. and PETACH TIKVAH, Israel, Jan. 11, 2016 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced the publication of a paper in the January 2016 edition of JAMA...

View More : http://www.prnewswire.com/news-releases/brainstorms-nurown-for-the-treatment-of-als-published-in-jama-neurology-30020207...
Releted News by prnewswire
Global Microtome Market 2021 Outlook and Competitive Landscape Analysis
Super Early Bird Registration is Now Open for AGILE2016 International Conference
Super Early Bird Anmeldung für die internationale AGILE2016 Konferenz ist ab sofort möglich
BrainStorm's NurOwn® for the Treatment of ALS Published in JAMA Neurology
Illinois Super Lawyers Recognize Simmons Hanly Conroy Attorneys
Carolco Names Jacqueline Journey COO